I am sure it will be the same. The untenable difference said with “some” board members. if it relates to science CSO imo should have the final say. If commercial then board majority. Was it under the radar, partner timing, cardio v FTO priority, capital raise and dilution, or combination, something else. We may never know…
Ann: Race Leadership Changes, page-339
-
- There are more pages in this discussion • 221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.47 |
Change
0.000(0.00%) |
Mkt cap ! $249.7M | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.49 | $1.46 | $54.22K | 36.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9188 | $1.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.48 | 200 | 1 |
View Market Depth
| Last trade - 12.03pm 13/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |